课题基金 / 基金详情

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.
第四届世界帕金森大会是为期四天的科学会议,旨在将美国和全球帕金森病界聚集在一起,举办各种高水平和新颖的教育研讨会。
批准号:
9194917
负责人:
SERGE E PRZEDBORSKI
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2017-09-19

项目摘要

项目成果

SERGE E PRZEDBORSKI的其他基金

相似基金

相关文献

中文摘要
翻译
第四届世界帕金森大会(WPC 2016)的目的是解决一个持续的问题 全球需要就帕金森ʼS病(PD)的多方面问题进行对话 并提出解决方案,包括新的研究方法和更好的护理模式 对警局的人来说。 2016 WPC将于2016年9月20日至23日举行,是唯一的国际 帕金森ʼS在帕金森领域的会议,将整个PD社区聚集在一起 水平科学会议和非科学会议。与会代表代表了神经科学家, 医生、帕金森病患者、护理伙伴、护士、康复专家、社会工作者 工人、政府代表和倡导社区的成员 将近70个国家。为期四天的课程突出了帕金森病科学的进步 以及对患有这种疾病的人的护理模式。曝光来自美国的研究人员 世界其他地区的科学进步将帮助他们探索新的 想法和建立合作,否则他们可能不会考虑。包含和 在这一重要会议上鼓励初级调查人员也可以建立联系 并与该领域的领导者接触,可以激励那些刚进入PD的人继续致力于 疾病,这是非常需要的! 来自PD社区的广泛支持和参与(170多个合作组织 来自近50个国家)表明,WPC是这些广泛传播的 用于会面和建立协作的小组。它将允许和鼓励 健康专业人员、研究人员和患有帕金森病的人以及可能不会 否则就会碰面。专家以及倡导者和想法的这种交叉授粉将 刺激新的创新研究,针对未得到满足的需求确定潜在的解决方案,推动 为帕金森氏症患者提供治疗,并激励代表们继续他们的工作。 包括帕金森病患者(PWP)在内的48名委员会成员设计了一个精心设计的 关于PD的独特方面的计划,以帮助深化研究人员和 临床医生对帕金森病进行研究,促进对帕金森病研究较少的方面的研究。这个 该计划预计将使PwP和照顾者接触到研究并增加对 参与临床试验。来自世界各地的180多位演讲者受到了邀请 PD社区,其会议的格式旨在最大限度地发挥学习潜力和对话, 包括大型和中等规模的以及令人难以置信的亲密圆桌会议 只有一名专家和10名参与者激烈讨论一个指定的主题。 三个大型的上午全体会议将研究PD和DBS的大脑回路,基因 和散发性帕金森病的机制,并给出干细胞和诱导性多能性细胞的最新进展。这些 全体会议将为以后的每一天会议的进一步讨论奠定基础。会有的 既是科学又是帕金森生活的ʼS海报以及海报会议和 旨在最大限度地促进代表之间互动的参观活动。四个最重要的 每天在基础和临床研究、临床治疗和 生活质量将在口头ʻ热门话题ʼ会议上展示,海报巡回将是 举办,密切关注该领域最有前途的工作并增加 社区中的对话和合作。
英文摘要
The purpose of the 4th World Parkinson Congress (WPC 2016) is to address a continued need for worldwide dialogue on the multifaceted problems of Parkinsonʼs disease (PD) and to propose solutions, including new approaches to research and better models of care for people with PD. The WPC 2016, to be held from September 20 to 23, 2016, is the only international meeting in the field of Parkinsonʼs that brings the whole PD community together for high- level scientific and lay sessions. Delegates at the meeting represent neuroscientists, physicians, people with PD, care partners, nurses, rehabilitation specialists, social workers, government representatives, and members of the advocacy community from nearly 70 countries. The four-day program highlights advancements in the science of PD and models of care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not have considered. Inclusion and encouragement of junior investigators in this important meeting also allows for networking and exposure to leaders in the field and can inspire those new to PD to stay dedicated to the disease, which is greatly needed! Broad support and involvement from the PD community (over 170 partnering organizations from nearly 50 countries) shows that the WPC is the right venue for these widespread groups to meet and build collaborations. It will allow and encourage interactions between health professionals, researchers, and people with PD and caregivers who might not otherwise meet. Such cross-pollination of experts, as well as advocates, and ideas will spur new innovative research, identify potential solutions to unmet needs, advance therapies for people with PD and inspire delegates to continue their work. Forty-eight committee members, including people with PD (PwP), designed an elaborate program about unique aspects of PD to help deepen the commitment of researchers and clinicians to PD research and foster research on less studied aspects of PD. The program is expected to expose PwPs and caregivers to research and increase interest in participating in clinical trials. Over 180 speakers are being invited from all areas of the PD community with sessions formatted to maximize the learning potential and dialogue, including large and moderately sized as well as incredibly intimate round table sessions with just one expert and 10 participants discussing one assigned topic intensely. The three large morning plenaries will look at the brain circuits in PD and DBS, genes and mechanisms of sporadic PD, and give an update on stem cells and iPs cells. These plenaries will set the stage for further discussion in later sessions each day. There will be both Scientific and Living with Parkinsonʼs posters as well as Poster sessions and tours which are designed to maximize interaction among the delegates. The four most outstanding posters each day in basic and clinical research, clinical therapeutics and quality of life will be presented in an oral ʻHot Topicsʼ session and poster tours will be held, paying keen attention to the most promising work in the field and to increase dialogue and collaboration in the community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
A multiplexable in vivo perturbation toolkit to identify genes affecting neurodegeneration in a model of synucleinopathy
Defining Immune Cell Heterogeneity in Human ALS and Mouse Model of the Disease
Defining immune cell heterogeneity in human ALS and mouse model of the disease
海外基金